Meridian Financial, LLC T2 Biosystems, Inc. Transaction History

Meridian Financial, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Aug 13, 2024	SELL	$1.06 - $545.0 $10,600 - $5.45 Million	-10,000 Closed	0 $0
Q2 2022 Aug 13, 2024	BUY	$0.15 - $0.54 $1,500 - $5,400	10,000 New	10,000 $1.62 Million

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.38M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Meridian Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Meridian Financial, LLC with notifications on news.